Funding, News and Announcements» Go to news main
2018 BSF Research Grant Program
The Barth Syndrome Foundation, Inc. (BSF) has announced the availability of funding for basic science and clinical research on the natural history, biochemical basis, and treatment of Barth syndrome. Barth syndrome (BTHS) is a serious X-linked genetic condition associated with cardiomyopathy, neutropenia, skeletal muscle weakness, exercise intolerance, growth delay, and diverse biochemical abnormalities (including defects in mitochondrial metabolism and phospholipid biosynthesis). BSF is seeking proposals for both basic science and clinical research that may shed light on any aspect of the syndrome with the object of developing a specific treatment or a cure.
There are two basic categories: IDEA grants for 1-2 years and DEVELOPMENT grants for 2-3 years with budgetary maximums of US $50,000 and $100,000, respectively. Note that for DEVELOPMENT grant applications only, a one-page Letter of Intent must be submitted by September 21, 2018.
Please see the BSF website for more details.
Any faculty member interested in this opportunity is asked to contact the International Research Manager in the Office of Research Services (email@example.com) for more information and support in preparing an application.
Deadline: October 31, 2018
- IMéRA Calls for Applications
- Shastri Indo‑Canadian Institute
- NFRF Exploration: Webinar Slides and Recording
- CIHR Project Grants: 2019 Fall competition
- Understanding Research Data Management Practices at Dalhousie University
- Canadian Blood Services ‑ CIHR Early Career Investigator Award in Transfusion Science
- PromoScience clarification
- New Frontiers in Research Fund: Exploration Stream